Duration of antibiotic therapy in the intensive care unit: factors influencing decision-making during multidisciplinary meetings
Our study identified numerous factors that influence decisions about the duration of antibiotic therapy during MDMs in the ICU. By describing these factors throughout the decision-making process, we provided valuable insights into barriers that commonly arise in specific steps, highlighting critical areas for improvement. Daily MDMs were deemed essential for informed decision-making regarding antibiotic therapy duration by the interviewees. Strategies to improve appropriate duration in the ICU should prioritise strengthening interdisciplinary communication between healthcare professionals and adding structure to these meetings.
Authors
- Jeroen Schouten (ORCID: https://orcid.org/0000-0001-9118-4420)
- Anke Oerlemans (ORCID: https://orcid.org/0000-0003-1791-1620)
- Johannes G. van der Hoeven (ORCID: https://orcid.org/0000-0001-5362-0244)
- N. Bos (ORCID: https://orcid.org/0000-0002-4155-3846)
- Evelien Oostdijk
- Heiman Wertheim (ORCID: https://orcid.org/0000-0002-5003-5565)
- Jaap ten Oever (ORCID: https://orcid.org/0000-0003-2397-0125)
- Robin Janssen (ORCID: https://orcid.org/0000-0001-8733-7295)
- Marlies Hulscher (ORCID: https://orcid.org/0000-0002-2160-4810)
- Lennie P. G. Derde (ORCID: https://orcid.org/0000-0002-3577-5629)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Rijnstate Hospital (NL)
Publication Details
- Journal
- BMJ Quality & Safety
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1136/bmjqs-2024-017796
- Citations
- 2
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 2.52
Funders
- Merck Sharp and Dohme